Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Pharmacorp Rx Inc. ( (TSE:PCRX) ) is now available.
PharmaCorp Rx Inc. has filed a preliminary short form base shelf prospectus in Canada, excluding Quebec, allowing the company to distribute up to $100 million in various securities over a 25-month period. This move is intended to provide the company with the flexibility to access capital markets efficiently, supporting its growth and acquisition strategy, particularly through its strategic alliance with PharmaChoice Canada.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. is a Canadian company focused on acquiring and operating pharmacies, empowering pharmacists as equity partners, and supporting succession for retiring pharmacy owners. The company operates under the PharmaChoice Canada banner and aims to build a national network of community pharmacies across Canada.
Average Trading Volume: 25,659
Technical Sentiment Signal: Sell
Current Market Cap: C$49.74M
For an in-depth examination of PCRX stock, go to TipRanks’ Overview page.